FG-001

N/A

Report date: 2024/03/01 15:09:35

Base Information

Drug NameFG-001
Drug Alias NameFG001FG-001
ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agent
Mechanisms of ActionDiagnostic imaging enhancersUrokinase plasminogen activator surface receptor inhibitors
TargetsUrokinase plasminogen activator surface receptor
Therapy Area/IndicationsLow-grade GliomaLung NeoplasmsBrain Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenDenmark
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesFluoGuide AS
China Registration ClassN/A

Develop Information

Active CompaniesCarl Zeiss Meditec AgOlympus CorpRigshospitalet +[4] 
Inactive CompaniesN/A
Active IndicationsLow-grade GliomaLung NeoplasmsBrain Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A